Physician profile
Cynthia Jun
NPI 1184627366
$3,466.55
in general payments reported to CMS, 2019-2025
18 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $178 · 2021: $223 · 2022: $2,081 · 2023: $195 · 2024: $256 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $569.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,766.16 | 2019-2022 | |
| Allergan, INC. | $339.33 | 2019-2022 | |
| Dompe US, INC. | $248.88 | 2021-2025 | Oxervate |
| Abbvie INC. | $147.93 | 2022-2023 | |
| Tarsus Pharmaceuticals, INC. | $113.87 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $111.91 | 2019 | |
| Sun Pharmaceutical Industries INC. | $110.81 | 2019-2021 | |
| Oyster Point Pharma, INC. | $109.69 | 2022-2023 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $107.56 | 2019 | |
| Novartis Pharmaceuticals Corporation | $100.46 | 2019-2023 | |
| Kala Pharmaceuticals, INC. | $86.89 | 2019-2021 | |
| Biotissue Holdings INC. | $84.95 | 2022-2023 | |
| Alcon Vision LLC | $27.92 | 2019-2021 | |
| Harrow Eye, LLC | $27.81 | 2024 | Vevye |
| Bausch & Lomb Americas INC. | $24.89 | 2024 | Miebo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $21.69 | 2022 | |
| Eyevance Pharmaceuticals LLC | $20.41 | 2022 | |
| Thea Pharma INC. | $15.39 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Jun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.